Titlebook: Alzheimer‘s Disease; Lit-Fui Lau,Michael A. Brodney Book 2008 Springer-Verlag Berlin Heidelberg 2008 Alzheimer.Medicinal Chemistry.Molecul

青春期

Herwart Opitz,Hans Obrig,Karlheinz Ganseroid plaques and neurofibrillary tangles in the brain.There is a?growing body of evidence to support a?central role for biometals such as copper (Cu),zinc (Zn) and iron (Fe) in many critical aspects of AD and other neurodegenerative diseases. The amyloidbeta (Aβ) peptide and its parental molecule, th

BRIBE

Herwart Opitz,Hans Obrig,Karlheinz Ganseriabetes mellitus, Alzheimer‘s disease, stroke, bipolardisorder and affective disorders. In the present review we briefly summarise the properties of GSK-3, focusingprimarily on the role of GSK-3 in Alzheimer‘s disease. Furthermore, we discuss the potential for therapeuticbenefit of GSK-3 inhibitors.

撫慰

,GSK-3 Inhibitors for the Treatment of Alzheimer’s Disease,iabetes mellitus, Alzheimer‘s disease, stroke, bipolardisorder and affective disorders. In the present review we briefly summarise the properties of GSK-3, focusingprimarily on the role of GSK-3 in Alzheimer‘s disease. Furthermore, we discuss the potential for therapeuticbenefit of GSK-3 inhibitors.

scotoma

PACK

978-3-642-09354-8Springer-Verlag Berlin Heidelberg 2008

ALTER

雪白

Herwart Opitz,Hans Obrig,Karlheinz Ganseriabetes mellitus, Alzheimer‘s disease, stroke, bipolardisorder and affective disorders. In the present review we briefly summarise the properties of GSK-3, focusingprimarily on the role of GSK-3 in Alzheimer‘s disease. Furthermore, we discuss the potential for therapeuticbenefit of GSK-3 inhibitors.

incision

Preamble

用樹皮

,Beyond Cholesterol: Statin Benefits in Alzheimer’s Disease,a. While early studies raised significant hopes, morerecent epidemiological studies suggest a?more complex association between cholesterol, statin use andAD. Despite the controversy, prospective randomized placebo control studies in AD do support cognitive benefitfrom statin treatment. The managemen